GLP-1 drugs could redefine public health: Swiss Re projects up to 6.4% lower U.S. mortality by 2045 if widely adopted .

Lilly’s oral GLP-1 pill orforglipron may win FDA fast-track approval this year—studies show 12.4% weight loss .

Sam Altman’s Retro is moving to human trials with RTR242, a pill to clear toxic Alzheimer’s proteins and add a “decade of life” .

A 30-year Harvard study of 105k adults found midlife plant-rich diets boost the odds of healthy aging at 70 by 86% .

The green-Mediterranean diet slowed brain aging, reducing proteins tied to cognitive decline .

UCSD scientists engineered vaccines that reprogram “immune-cold” tumors with 9p-loss, paving the way for personalized cancer vaccines .

A triple therapy for glioblastoma—electric fields + immunotherapy + chemo—lifted survival by 70%, especially in large tumors .

UCLH launched the GB-PRIME trial of Neuralink’s N1 implant, threading 1,000 electrodes to help patients with paralysis control devices .

Nature reported an AI-assisted BCI that let a paralyzed man use a robotic arm 4× more effectively than standard control .

Germany’s CorTec implanted the first fully closed-loop Brain Interchange system, delivering real-time stimulation for stroke recovery .

From drugs to diets, vaccines to neurotech, the frontier of longevity is converging—pushing healthspan closer to outpacing lifespan.